Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (4): 61-67.doi: 10.6040/j.issn.1671-7554.0.2024.0303
• Clinical Medicine • Previous Articles
LIU Chao1,2*, DIAO Tingting1,2*, ZHANG Hongji1,2, LIU Hongwei1, YANG Yongrui1, LI Xiaofei1
CLC Number:
[1] World Health Organization. Global tuberculosis report 2023[ER/OL] [2023-11-7] (2024-3-25). http://iris.who.int/bitstream/handle/10665/373828/9789240083851-eng.pdf?sequence=1 [2] Yang J, Zhang L, Qiao W, et al. Mycobacterium tuberculosis: pathogenesis and therapeutic targets[J]. Med Comm, 2023, 4(5): e353. doi: 10.1002/mco2.353. [3] Georghiou SB, Schumacher SG, Rodwell TC, et al. Guidance for studies evaluating the accuracy of rapid tuberculosis drug-susceptibility tests[J]. J Infect Dis, 2019, 220(Suppl 3): S126-S135. [4] Domínguez J, Boeree MJ, Cambau E, et al. Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement[J]. Lancet Infect Dis, 2023, 23(4):e122-e137. [5] MacLean E, Kohli M, Weber SF, et al. Advances in molecular diagnosis of tuberculosis[J]. J Clin Microbiol, 2020, 58(10):e01582-19. doi: 10.1128/JCM.01582-19. [6] Amer S, EL Hefnawy A, Baz A, et al. Evaluation of tuberculosis diagnostic tools, with extending MODS assay use to second line susceptibility testing[J]. Epidemiol Mikrobiol Imunol, 2021, 70(3): 161-167. [7] 李晓非,黄山,欧阳兵,等.利福平耐药实时荧光定量核酸扩增技术在肺结核临床路径中的应用[J].山东大学学报(医学版),2018, 56(6): 35-40. LI Xiaofei, HUANG Shan, OUYANG Bing, et al. Applicative value of gene Xpert MTB /RIF for the rapid detection of pulmonary tuberculosis in the clinical pathway[J]. Journal of Shandong University(Health Sciences), 2018, 56(6): 35-40. [8] 李晓非,刘红伟,资敏,等. 全自动化学发光法检测γ-干扰素试验诊断结核病的临床应用[J].山东大学学报(医学版),2019, 57(11): 34-41. LI Xiaofei, LIU Hongwei, ZI Min, et al. Clinical application of the fully automatic chemiluminescence to detect interferon-γtest in diagnosis of tuberculosis [J]. Journal of Shandong University(Health Sciences), 2019, 57(11): 34-41. [9] Allix-béguec C, Arandjelovic I, Bi L, et al. Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing [J]. N Engl J Med, 2018, 379(15): 1403-1415. [10] Wu X, Tan G, Yang J, et al. Prediction of mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS [J]. Int J Infect Dis, 2022, 121: 47-54. doi: 10.1016/j.ijid.2022.04.061. [11] Yang H, Li A, Dang L, et al. A rapid, accurate, and low-cost method for detecting Mycobacterium tuberculosis and its drug-resistant genes in pulmonary tuberculosis: applications of massARRAY DNA mass spectrometry [J]. Front Microbiol, 2023, 14: 1093745. doi: 10.3389/fmicb.2023.1093745. [12] Tsuchida S, Umemura H, Nakayama T. Current status of matrix-assisted laser desorption/Ionization-time-of-flight mass spectrometry(MALDI-TOF MS)in clinical diagnostic microbiology [J]. Molecules(Basel, Switzerland), 2020, 25(20): 4775. doi:10.3390/molecules25204775. [13] 余艳芳,赵开顺,屠春林,等. 基质辅助激光解析电离飞行时间质谱在结核分枝杆菌耐药检测中的应用价值研究[J]. 实用心脑肺血管病杂志, 2021, 29(10): 106-112. YU Yanfang, ZHAO Kaishun, TU Chunlin, et al. Application value of matrix-assisted laser desorption ionization time-of-flight mass spectrometry in the detection of drug resistance of Mycobacterium tuberculosis [J]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, 2021, 29(10): 106-112. [14] Miao Qing, Ma Yuyan, Wang Qingqing, et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice. Clin Infect Dis, 2018, 67(Suppl 2): S231-S240. [15] Yonkus JA, Whittle E, Alva-Ruiz R, et al. "Answers in hours": a prospective clinical study using nanopore sequencing for bile duct cultures[J]. Surgery, 2022, 171(3): 693-702. [16] Consortium C, Allix-Béguec C, Arandjelovic I, et al. Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing[J]. N Engl J Med, 2018, 379(15): 1403-1415. [17] Tang W, Hu J, Zhang H, et al. Kappa coefcient: a popular measure of rater agreement[J]. Shanghai Arch Psychiatry, 2015, 27(1): 62-67. [18] Liang J, Wu X, An H. Expert consensus on the clinical application of nucleic acid MALDI-TOF MS technique in the diagnosis of tuberculosis and non-tuberculosis mycobacteriosis[J]. Chin J Antituberc, 2023, 45(6): 543-558. [19] OviaÑo M, Gato E, Bou G. Rapid detection of KPC-producing enterobacterales susceptible to imipenem/relebactam by using the MALDI-TOF MS MBT STAR-Carba IVD assay [J]. Front Microbiol, 2020, 11: 328. doi: 10.3389/fmicb.2020.00328. [20] Kent L, McHugh TD, Billington O, et al. Demonstration of homology between IS6110 of Mycobacterium tuberculosis and DNAs of other Mycobacterium spp? [J]. J Clin Microbiol, 1995, 33(9): 2290-2293. [21] 谢彤,孙蕊,巨韩芳,等. 结核分枝杆菌北京基因型菌株大片段的多态性研究[J]. 中国防痨杂志, 2018, 40(3): 269-273. XIE Tong, SUN Rui, JU Hanfang, et al. Large sequence polymorphisms of the Mycobacterium tuberculosis Beijing genotype strains [J]. Chinese Journal of Antituberculosis, 2018, 40(3): 269-273. [22] Halse TA, Escuyer VE, Musser KA. Evaluation of a single-tube multiplex real-time PCR for differentiation of members of the Mycobacterium tuberculosis complex in clinical specimens[J]. J Clin Microbiol, 2011, 49(7): 2562-2567. [23] 李爱芳,曹俊杰,杨翰,等. MassARRAY核酸质谱在结核分枝杆菌检测中的应用价值[J]. 国际呼吸杂志,2023, 43(10):1149-1156. LI Aifang, CAO Junjie, YANG Han, et al. Application value of MassARRAY nucleic acid masss pectrometry in the detection of Mycobacterium tuberculosis[J]. International Journal of Respiration, 2023, 43(10): 1149-1156. [24] 江华,王琳,汤玲玲,等. 目标管理在提高初治肺结核患者痰标本留取质量上的价值[J]. 中国防痨杂志, 2019, 41(6): 676-680. JIANG Hua, WANG Lin, TANG Lingling, et al. The value of target management in improving the quality of sputum samples retention of initially treated pulmonary tuberculosis patients[J]. Chinese Journal of Antituberculosis, 2019, 41(6): 676-680. [25] Chen Y, Ji L, Liu Q, et al. Lesion heterogeneity and long-term heteroresistance in multidrug-resistant tuberculosis [J]. J Infect Dis, 2021, 224(5): 889-893. |
[1] | GE Li-Juan, JIN Rui-Feng, WANG Ji-Wen, HU Xin-Sheng, LIKun. Association between the C1236T polymorphism in multi-drug resistance gene 1 and response to antiepileptic drug treatment in epileptic patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 99-102. |
[2] | LIU Na, WANG Nana, JI Bing, DING Xuemei, LIU Yaxin, FANG Xiaoqing, ZHANG Xiaoli. Distribution and drug resistance changes of pathogenic bacteria in hospitalized elderly inpatients from 2012 to 2021 [J]. Journal of Shandong University (Health Sciences), 2023, 61(6): 29-40. |
[3] | JIN Xinjuan, ZUO Liping, DENG Zhanhao, LI Anning, YU Dexin. Value of enhanced MRI radiomics in predicting the drug-resistant protein PFKFB3 in 135 cases of hepatocellular carcinoma [J]. Journal of Shandong University (Health Sciences), 2023, 61(6): 79-86. |
[4] | LI Yan, LIU Jing, LI Juan, YANG Qiuhong. Clinical characteristics and placental pathology of bloodstream infection in 50 pregnant women [J]. Journal of Shandong University (Health Sciences), 2022, 60(1): 48-54. |
[5] | HA Chunfang, LI Ruyue. Research progress of drug resistance in ovarian cancer and targeted therapy strategy [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 117-123. |
[6] | JU Jianhua, YANG Zhenye, LI Qinglian, HAN Yanan, LI Yanqing, QIAO Yijun, YANG Hu, ZHANG Huaran. Advances on drugs derived from microbial sources and future perspectives [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 43-50. |
[7] | XU Bing, LI Yong, LIU Ming, LIU Yonghui. Silencing PRRX1 gene expression enhances the sensitivity of prostate cancer resistant cell line PC-3/DTX to docetaxel [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 103-110. |
[8] | FU Zhenmei, MA Mingze. Expression of P-glycoprotein in the colonic mucosa of ulcerative colitis patients and its clinical significance [J]. Journal of Shandong University (Health Sciences), 2020, 58(12): 54-59. |
[9] | ZHANG Ning, YANG Yan, LI Rui, YIN Yunhong, LI Hao, QU Yiqing. Analysis of risk factors and drug resistance of Acinetobacter baumannii in patients with chronic obstructive pulmonary disease [J]. Journal of Shandong University (Health Sciences), 2019, 57(9): 88-96. |
[10] | WANG Chuanxin. Research progress of exosomes biomarkers in tumor development [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 18-23. |
[11] | MENG Wei, WU Dawei, SHAN Tichao, ZHANG Fan, GUO Haipeng, LIU Yu, DING Shifang, ZHAI Qian. Tigecycline in treating ventilator-associated pneumonia in critically ill patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(4): 71-75. |
[12] | YUAN Yuan, SI Heng, LIU Hongwei, LIU Chunhua, WANG Zhe, RUAN Yuhua, XING Hui. HIV drug resistance and the impact of antiretroviral therapy initiated at different stages among AIDS patiens [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(9): 77-81. |
[13] | LIU Qiong, PU Yedi, DAI Guangxia, MA Jiale, YANG Jianxia, LI Lizhen, LI Hao, WANG Luqun. A microarray analysis of bortezomib-resistant gene expression in multiple myeloma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 33-38. |
[14] | LIU Zhenyan, HU Bin, BI Zhenwang, KOU Zengqiang, FANG Ming, CHEN Baoli, REN Yanyan, BI Zhenqiang. Antibiotic resistance on group A streptococcus among children in 4 cities of Shandong Province in 2013 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(1): 77-80. |
[15] | ZHANG Cheng-mei1, WU Chuan-tao1, ZHU Shan-shan2, JIA Shu3, WANG Yi4, Shi Yan-qiu1,2. Effect and mechanism of deacetyl-mycoepoxydiene on reversing resistance to taxol in tumor cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(4): 21-25. |
|